Landmark Study of 1.4 Million Women Identifies New Genetic Regions and Biological Pathways Linked to Endometriosis

International research involving 1.4 million women identifies 80 genetic regions linked to endometriosis, paving the way for better diagnosis and treatments.

By: AXL Media

Published: May 1, 2026, 4:44 AM EDT

Source: Information for this report was sourced from EurekAlert

Mapping the Genetic Architecture of a Complex Condition

An expansive international study has analyzed the genetic profiles of nearly 1.4 million women, including over 100,000 confirmed cases of endometriosis, to better understand the molecular foundations of the disease. This research, which stands as the largest of its kind, identified 80 distinct regions of the genome associated with endometriosis risk, 37 of which had never been previously described. By uncovering these new genetic markers, scientists are moving closer to defining the biological complexity of a condition that affects approximately 190 million women globally, yet remains notoriously difficult to diagnose and treat effectively.

Bridging Statistical Data and Biological Mechanisms

The research team, which included experts from Yale University, the University of Barcelona, and the Sant Pau Research Institute, employed an integrative approach to translate statistical associations into functional biological knowledge. Rather than simply identifying risk variants, the study combined genetic data with information on gene expression, protein production, and epigenetic processes. According to lead author Dr. Dora Koller, understanding these molecular events is essential for developing targeted treatments. The findings suggest that endometriosis is driven by a symphony of interrelated processes, including inflammation, immune system alterations, and the formation of new blood vessels.

Clinical Variability and the Challenge of Categorization

The biological complexity identified in the study mirrors the extreme clinical variability seen in patients, ranging from asymptomatic cases to those involving severe chronic pain and infertility. Currently, medical professionals classify endometriosis based on surgical findings or lesion location, but these criteria often fail to predict a patient's symptoms or response to therapy. Dr. Koller emphasizes the need for a classification system based on biological subtypes, similar to modern oncology. Such a shift is intended to address the systemic diagnostic delay, which currently averages seven to ten years even when debilitating symptoms are present.